News

Procter & Gamble (NYSE:PG) is buying its way into wellness. On August 4, L Catterton announced it had signed a definitive agreement to sell Thorne, a science-backed health and wellness brand, to Procter & Gamble for $3.8 billion in cash. The deal lands a day after an August 3 analysis flagged a fiscal 2027 earnings […]

Procter & Gamble just logged its 70th consecutive dividend increase, yet Wall Street has turned skeptical, pointing to tariff costs, margin compression, and guidance at the lower end of its range. The cash flow statement is telling a completely different story.

Procter & Gamble (NYSE:PG) appointed Shailesh Jejurikar as Chairman of the Board, succeeding Jon R. Moeller following his retirement after 38 years at the company. The board transition shifts leadership at the top of Procter & Gamble’s governance structure as Moeller steps down from his role as Executive Chairman. Investors are watching the handover closely, given the potential long term implications for company culture, operations, and board oversight. For readers tracking long term...

A $425,000 nest egg can generate wildly different monthly paychecks depending on where you put it, but chasing the biggest number often destroys the very asset you need to last through your 70s.

Replicating a Social Security check with dividends sounds straightforward until you realize the yield you chase determines whether your income grows, stalls, or quietly disappears over the next two decades.

Consumer sentiment is flashing recession warnings, yet three blue-chip dividend legends are quietly building cases for returns that would shock most defensive investors heading into 2027.

Chasing a $50,000 monthly dividend stream sounds like a math problem, but the yield you pick determines whether your portfolio funds four decades of freedom or quietly cannibalizes itself while the checks keep arriving.

P&G navigates $1B cost headwind while guiding 1-3% organic sales growth for fiscal 2027.

A $1.25 million nest egg can fund a very different retirement depending on one number: your withdrawal yield. The gap between a conservative dividend portfolio and an aggressive one swings your annual income by tens of thousands of dollars, but the safer-looking choice does not always win.

Earnings season is showing that consumers are still spending and paying their bills, as indicated by SoFi and Visa.

With the 10-year Treasury yield near 4.70%, dividend stocks face a real test of relevance, and only a handful of names have the streak length and earnings power to still make the cut right now.

NHTC, HCWC, and NAII sell into the growing nutrition and wellness space.

An 8% yield looks like a shortcut to $80,000 a year without selling a single share, but the brokerage account tells a different story than the headline number does.

Procter & Gamble stock rallies on $3.8 billion acquisition of Thorne. Here’s what the deal means for PG shares.

Wayfair CFO Kate Gulliver on signs of a rebound in the U.S.; Elon Musk outlined ambitious targets for SpaceX following its first-ever earnings report; Procter & Gamble will buy supplement company Thorne; plus, Portillo’s hires new CFO. Furniture and home improvement companies often offer good indicators for how the U.S. economy is performing, as those businesses reflect the sentiment of consumers and key discretionary spending behavior for items such as sofas, tables and decor.

Annuity payouts are the most competitive they have been in years, which makes the timing of this comparison unusually consequential for anyone sitting on a $675,000 nest egg and trying to decide which structure actually puts more money in their pocket for life.

Replacing a six-figure salary with dividends is a math problem first, and the capital requirement swings by more than a million dollars depending on one variable most investors treat as an afterthought.

Procter & Gamble (NYSE:PG) agreed to acquire Thorne, a science-focused wellness supplements company. The transaction values Thorne at US$3.8b and expands PG into premium health and wellness categories. The deal centers on vitamins, minerals, and supplements as an extension of PG's existing health portfolio. For investors tracking Procter & Gamble, this move pushes the company further into consumer health and wellness rather than relying only on traditional household and personal care...

The acquisition bolsters P&G's presence in the premium wellness space.

The deal, set to close later this year, would add Thorne to P&G's existing supplements portfolio that includes Metamucil, Align Probiotic, and New Chapter

Investing.com -- Procter & Gamble Co. reached an agreement to acquire supplement maker Thorne for $3.8 billion, with the deal set to be announced later today.

Thorne went public in late 2021 at a $525 million valuation but was taken private by asset manager L Catterton in 2023 in a $680 million transaction.

The consumer-goods giant will buy Thorne to bolster its presence in the beauty and wellness industry.

These relatively safe dividend stocks offer yields of more than 3%.

Procter & Gamble has underperformed the broader market over the past year, though analysts remain moderately optimistic on its future potential.

Consumer products behemoth Procter & Gamble (NYSE:PG) fell short of the market’s revenue expectations in Q2 CY2026 as sales only rose 1.5% year on year to $21.2 billion. Its non-GAAP profit of $1.43 per share was 1.6% above analysts’ consensus estimates.

Your portfolio could be paying you quarterly income right now from three companies that have raised their dividends for decades straight, but the next ex-dates are approaching fast and missing them means waiting another quarter to collect.

The newly installed boss of Diageo has poached a senior Procter & Gamble (P&G) executive to join his leadership team, days before he unveils a revival plan for the maker of Guinness and Johnnie Walker. Sky News has learnt that Sujay Wasan, the head of P&G's oral care business in North America, is joining the FTSE-100 alcoholic drinks company as the head of its Asia-Pacific operations.

A 3% yield near a 52-week low is tempting -- but the new guidance explains why I'm waiting.

Most income investors can name Coca-Cola and Procter & Gamble as Dividend Kings, but four quiet compounders with 50-plus years of consecutive increases keep flying under the radar, including one gas utility on a streak that dwarfs nearly every name in the group.